Authors: | Shah, B. D.; Ghobadi, A.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Cassaday, R. D.; Leguay, T.; Bishop, M. R.; Topp, M. S.; Tzachanis, D.; O'Dwyer, K. M.; Arellano, M. L.; Lin, Y.; Baer, M. R.; Schiller, G. J.; Park, J. H.; Subklewe, M.; Abedi, M.; Minnema, M. C.; Wierda, W. G.; DeAngelo, D. J.; Stiff, P.; Jeyakumar, D.; Dong, J.; Adhikary, S.; Zhou, L.; Schuberth, P. C.; Faghmous, I.; Masouleh, B. K.; Houot, R. |
Abstract Title: | Updated outcomes from the historical control study SCHOLAR-3 contextualizing ZUMA-3 results of brexucabtagene autoleucel (KTE-X19) in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) |
Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
Journal Title: | Blood |
Volume: | 140 |
Issue: | Suppl. 1 |
Meeting Dates: | 2022 Dec 10-13 |
Meeting Location: | New Orleans, LA |
ISSN: | 0006-4971 |
Publisher: | American Society of Hematology |
Date Published: | 2022-11-15 |
Start Page: | 3158 |
End Page: | 3161 |
Language: | English |
ACCESSION: | WOS:000893223203086 |
DOI: | 10.1182/blood-2022-158248 |
PROVIDER: | wos |
Notes: | Meeting Abstract -- Source: Wos |